COVID-19 Presentation in Association with Myasthenia Gravis: A Case Report and Review of the Literature

Currently, there are scarce data on how COVID-19 affects people with myasthenia gravis. Theoretically, there is a higher risk of experiencing severe manifestations of COVID-19 due to the common use of immunosuppressive drugs and potential respiratory failure in relation to respiratory muscle weaknes...

Descripción completa

Detalles Bibliográficos
Autores principales: Aksoy, Elif, Oztutgan, Turgut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436352/
https://www.ncbi.nlm.nih.gov/pubmed/32850160
http://dx.doi.org/10.1155/2020/8845844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436352/
https://www.ncbi.nlm.nih.gov/pubmed/32850160
http://dx.doi.org/10.1155/2020/8845844

Ejemplares similares